Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05840042

Epidemiology and Risk Factors of Uterine Fibroids in China

Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Current place of residence≥ 6 months;
  • No serious mental illness or mental abnormality;
  • Those who agree to participate in this survey and cooperate in completing the questionnaire.

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Prevalence of uterine fibroids in China

    Time frame: Baseline

    Prevalence of uterine fibroids in China

Secondary outcomes

  1. Incidence of uterine fibroids in China

    Time frame: Two follow-ups over a three-year period

    Incidence of uterine fibroids in China

  2. Risk factors of development of uterine fibroids in China

    Time frame: Two follow-ups over a three-year period

    Associated risk factors for recurrence, infertility and malignancy of uterine fibroids in China

Study contacts

Contact information is provided by the study sponsor or research team.

MINLI ZHANG, MASTER

CONTACT

WENWEN WANG, DOCTOR

CONTACT

[email protected]

15927167698

Sponsors and collaborators

Lead sponsor

Shixuan Wang

Other

Collaborators

  • First Affiliated Hospital, Sun Yat-Sen University
  • The Fourth Hospital of Shijiazhuang
  • Tongji Hospital
  • West China Hospital
  • Women's Hospital School Of Medicine Zhejiang University

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
May 3, 2023
Registry last updated
Jun 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.